Reference: Morens, D. M., Taubenberger, J. K., & Fauci, A. S. (2023). Rethinking next-generation vaccines for coronaviruses, influenza viruses, and other respiratory viruses. Cell Host & Microbe, 31, 146-157. https://doi.org/10.1016/j.chom.2022.11.016 Summary: The article discusses the challenges in developing effective vaccines for respiratory viruses such as SARS-CoV-2 and influenza. These viruses often replicate rapidly in the […]
Reference: Morens, D. M., Taubenberger, J. K., & Fauci, A. S. (2023). Rethinking next-generation vaccines for coronaviruses, influenza viruses, and other respiratory viruses. Cell Host & Microbe, 31, 146–157. https://doi.org/10.1016/j.chom.2022.11.016 Summary: The authors discuss the challenges in developing effective vaccines for respiratory viruses like influenza and SARS-CoV-2. They highlight that these viruses replicate rapidly in
Reference: UK Health Security Agency. (2022). Weekly national influenza and COVID-19 surveillance report: Week 27 report (up to week 26 data). Retrieved from [link] Summary: The report provides an overview of COVID-19 and influenza surveillance in England for week 26 of 2022, highlighting an increase in COVID-19 cases, particularly among individuals over 80. Laboratory data
Reference: UK Health Security Agency. (2022). Weekly national influenza and COVID-19 surveillance report: week 5 report (up to week 4 data). Summary: The UK Health Security Agency’s report for Week 5 of 2022 highlights a decrease in COVID-19 activity in England during Week 4, with reductions in case rates across various demographics. While positive rates
Reference: Levy, T. E. (2020). An at-home treatment that can cure any virus, including coronavirus. Retrieved from www.PeakEnergy.com Summary: The article discusses a simple and inexpensive treatment for viral infections, including COVID-19, using 3% hydrogen peroxide. Originally conceptualised by Dr. Charles Farr, this therapy targets infected cells rather than the viruses themselves, which cannot be
Reference: Pardi, N., Hogan, M. J., Porter, F. W., & Weissman, D. (2018). mRNA vaccines — a new era in vaccinology. Nature Reviews Drug Discovery, 17(4), 261-279. https://doi.org/10.1038/nrd.2017.243 Summary: mRNA vaccines offer a potent alternative to traditional vaccine approaches due to their rapid development and cost-effective manufacturing. They have shown promise in preventing infectious diseases
Reference: Bahl, K., Senn, J. J., Yuzhakov, O., Bulychev, A., Brito, L. A., Hassett, K. J., Laska, M. E., Smith, M., Almarsson, Ö., Thompson, J., Ribeiro, A. (Mick), Watson, M., Zaks, T., & Ciaramella, G. (2017). Preclinical and clinical demonstration of immunogenicity by mRNA vaccines against H10N8 and H7N9 influenza viruses. Molecular Therapy, 25(6), 1316-1326.
Reference: Crump, A. (2017). Ivermectin: enigmatic multifaceted ‘wonder’ drug continues to surprise and exceed expectations. The Journal of Antibiotics, 70(6), 495-505. https://doi.org/10.1038/ja.2017.11 Summary: Over the last decae, ivermectin has gained recognition for its significant contributions to global health. Discovered from a soil microbe in Japan, it was developed by Satoshi Ōmura and William Campbell, who
Reference: Jacobson, J. M., Routy, J.-P., Welles, S., DeBenedette, M., Tcherepanova, I., Angel, J. B., Asmuth, D. M., Stein, D. K., Baril, J.-G., McKellar, M., Margolis, D. M., Trottier, B., Wood, K., & Nicolette, C. (2016). Dendritic cell immunotherapy for HIV-1 infection using autologous HIV-1 RNA: A randomized, double-blind, placebo-controlled clinical trial. Journal of Acquired
Reference: Gandhi, R. T., Kwon, D. S., Macklin, E. A., Shopis, J. R., McLean, A. P., McBrine, N., Flynn, T., Peter, L., Sbrolla, A., Kaufmann, D. E., Porichis, F., Walker, B. D., Bhardwaj, N., Barouch, D. H., & Kavanagh, D. G. (2016). Immunization of HIV-1-Infected Persons With Autologous Dendritic Cells Transfected With mRNA Encoding HIV-1